AFRICTRIMS: Should exclusion of NMOSD/MOGAD be a prerequisite for initiating MS disease-modifying therapy? - Commentary. Hedström A K Mult Scler. 2026 Sep 21:13524585261489062. PMID: 42765665. Abstract CommentRecommendBookmarkWatch
